Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases

Bioorg Med Chem Lett. 2011 Jan 15;21(2):781-5. doi: 10.1016/j.bmcl.2010.11.100. Epub 2010 Nov 30.

Abstract

A novel series of 5-((4-aminopiperidin-1-yl)methyl)-pyrrolo[2,1-f][1,2,4]triazin-4-amines with small aniline substituents at the C4 position were optimized for dual EGFR and HER2 protein tyrosine kinase inhibition. Compound 8l exhibited promising oral efficacy in both EGFR and HER2-driven human tumor xenograft models.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • Colonic Neoplasms / drug therapy
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Models, Molecular
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Protein-Tyrosine Kinases / chemistry*
  • Protein-Tyrosine Kinases / pharmacokinetics
  • Protein-Tyrosine Kinases / pharmacology
  • Protein-Tyrosine Kinases / therapeutic use*
  • Pyrroles / chemistry
  • Pyrroles / pharmacokinetics
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use
  • Receptor, ErbB-2 / antagonists & inhibitors*
  • Receptor, ErbB-2 / metabolism
  • Stomach Neoplasms / drug therapy
  • Triazines / chemistry
  • Triazines / pharmacokinetics
  • Triazines / pharmacology
  • Triazines / therapeutic use
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Pyrroles
  • Triazines
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • Receptor, ErbB-2